06628.HK
Transcenta Holding Limited
HKSE · Healthcare · Biotechnology · CN
HKD 0.98
+17.47%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 1.87x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.62x
- Price / sales
- 12.19x
- Price / cash flow
- -5.76x
Enterprise value
- Enterprise value
- HKD 560.9M
- EV / sales
- 16.94x
- EV / EBITDA
- -4.66x
- EV / EBIT
- -3.23x
- Market cap
- HKD 403.8M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026